Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.
about
Current status of human papillomavirus vaccinesAdditive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteinsSmall molecule inhibitors of human papillomavirus protein - protein interactions.Global challenges of implementing human papillomavirus vaccines.Comparison of Gene Expression by Sheep and Human Blood Stimulated with the TLR4 Agonists Lipopolysaccharide and Monophosphoryl Lipid A.Perceptions of Nigerian Women about Human Papilloma Virus, Cervical Cancer, and HPV Vaccine.A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivoHuman papillomavirus vaccination in HIV-infected women: need for increased coverage.Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults.Qualitative responses to a national physician survey on HPV vaccinationSociety of behavioral medicine supports increasing HPV vaccination uptake: an urgent opportunity for cancer prevention.Comparative Transcriptome Profiles of Human Blood in Response to the Toll-like Receptor 4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A.Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.Escherichia coli-derived virus-like particles in vaccine development.Applications of chemokines as adjuvants for vaccine immunotherapy.Progress Toward the Clinical Translation of Bioinspired Peptide and Protein Assemblies.Designing of CD8 and CD8-overlapped CD4 epitope vaccine by targeting late and early proteins of human papillomavirus
P2860
Q26991640-F7109EDB-9EE7-4830-88D3-5B086E58AE60Q34616642-1901C6FB-F797-41AC-8644-E28D0BDAADDDQ35107717-C430ADE5-A5F8-4ED6-B18C-A0D97579E850Q35128768-7BD0A160-C61A-45F4-BE17-98E738BA6FA6Q35862009-F5D3E41D-9709-4C1A-904A-FA4D546B2B3CQ36208965-4912DF1E-7C17-412C-A03D-085D7BD3E82EQ36452968-7BA49575-0BEC-4344-A994-B3467B6D07ACQ36780952-B3DF0A06-694E-444D-982F-2CACBED41BB2Q36977831-8E5729C7-9A24-434B-A2FD-7C5902AFEC92Q37309804-A0B4C8FE-77AE-48ED-8AEB-8294A6969EA1Q37416019-795C2006-7B72-4560-A20E-68F824FD3BB5Q37560510-CC2A725F-26CA-4B80-83A8-8E85AC20ACD3Q40077472-A76C5BF1-8523-43DC-A910-4C872605B24CQ47132009-0D1AB971-AD89-4055-88CD-1A805B6706C7Q47288431-BCFA9246-E760-40ED-9D1E-BC1356A70A6EQ47370297-586738F3-A945-46E8-BE33-4C252AF1F761Q57484891-AE559770-A56B-4503-B012-4A526E1AC80F
P2860
Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.
@en
Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.
@nl
type
label
Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.
@en
Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.
@nl
prefLabel
Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.
@en
Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.
@nl
P2093
P2860
P1476
Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer
@en
P2093
Archana Monie
Chien-Fu Hung
Richard Roden
P2860
P304
P577
2008-03-01T00:00:00Z